These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21673672)

  • 1. Molecular basis for class Ib anti-arrhythmic inhibition of cardiac sodium channels.
    Pless SA; Galpin JD; Frankel A; Ahern CA
    Nat Commun; 2011 Jun; 2():351. PubMed ID: 21673672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action.
    Fredj S; Sampson KJ; Liu H; Kass RS
    Br J Pharmacol; 2006 May; 148(1):16-24. PubMed ID: 16520744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Charge at the lidocaine binding site residue Phe-1759 affects permeation in human cardiac voltage-gated sodium channels.
    McNulty MM; Edgerton GB; Shah RD; Hanck DA; Fozzard HA; Lipkind GM
    J Physiol; 2007 Jun; 581(Pt 2):741-55. PubMed ID: 17363383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State-dependent block of human cardiac hNav1.5 sodium channels by propafenone.
    Edrich T; Wang SY; Wang GK
    J Membr Biol; 2005 Sep; 207(1):35-43. PubMed ID: 16463141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Gating Properties and Use-Dependent Block of Nav1.5 and Nav1.7 Channels by Anti-Arrhythmics Mexiletine and Lidocaine.
    Wang Y; Mi J; Lu K; Lu Y; Wang K
    PLoS One; 2015; 10(6):e0128653. PubMed ID: 26068619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modernized Classification of Cardiac Antiarrhythmic Drugs.
    Lei M; Wu L; Terrar DA; Huang CL
    Circulation; 2018 Oct; 138(17):1879-1896. PubMed ID: 30354657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac Na+ channels as therapeutic targets for antiarrhythmic agents.
    Glaaser IW; Clancy CE
    Handb Exp Pharmacol; 2006; (171):99-121. PubMed ID: 16610342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the relationship between block of the cardiac Na⁺ channel and drug-induced prolongation of the QRS complex.
    Harmer AR; Valentin JP; Pollard CE
    Br J Pharmacol; 2011 Sep; 164(2):260-73. PubMed ID: 21480866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State-dependent trapping of flecainide in the cardiac sodium channel.
    Ramos E; O'leary ME
    J Physiol; 2004 Oct; 560(Pt 1):37-49. PubMed ID: 15272045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxylated analogs of mexiletine as tools for structural-requirements investigation of the sodium channel blocking activity.
    Catalano A; Carocci A; Cavalluzzi MM; Di Mola A; Lentini G; Lovece A; Dipalma A; Costanza T; Desaphy JF; Conte Camerino D; Franchini C
    Arch Pharm (Weinheim); 2010 Jun; 343(6):325-32. PubMed ID: 20509146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput electrophysiological assays for voltage gated ion channels using SyncroPatch 768PE.
    Li T; Lu G; Chiang EY; Chernov-Rogan T; Grogan JL; Chen J
    PLoS One; 2017; 12(7):e0180154. PubMed ID: 28683073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into the therapeutic inhibition of voltage-gated sodium channels.
    Ahern CA; Eastwood AL; Dougherty DA; Horn R
    Channels (Austin); 2008; 2(1):1-3. PubMed ID: 18690056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of ion permeability in a voltage-gated sodium channel.
    Naylor CE; Bagnéris C; DeCaen PG; Sula A; Scaglione A; Clapham DE; Wallace BA
    EMBO J; 2016 Apr; 35(8):820-30. PubMed ID: 26873592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking Scn10a channels in heart reduces late sodium current and is antiarrhythmic.
    Yang T; Atack TC; Stroud DM; Zhang W; Hall L; Roden DM
    Circ Res; 2012 Jul; 111(3):322-32. PubMed ID: 22723299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New aspects of the electrophysiologic effect of antiarrhythmic agents].
    Antoni H; Weirich J
    Herz; 1990 Apr; 15(2):61-9. PubMed ID: 2188893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic overlap of cardiac sodium channelopathies: individual-specific or mutation-specific?
    Makita N
    Circ J; 2009 May; 73(5):810-7. PubMed ID: 19336922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrostatic contributions of aromatic residues in the local anesthetic receptor of voltage-gated sodium channels.
    Ahern CA; Eastwood AL; Dougherty DA; Horn R
    Circ Res; 2008 Jan; 102(1):86-94. PubMed ID: 17967784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State- and use-dependent block of muscle Nav1.4 and neuronal Nav1.7 voltage-gated Na+ channel isoforms by ranolazine.
    Wang GK; Calderon J; Wang SY
    Mol Pharmacol; 2008 Mar; 73(3):940-8. PubMed ID: 18079277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autonomic modulation and antiarrhythmic therapy in a model of long QT syndrome type 3.
    Fabritz L; Damke D; Emmerich M; Kaufmann SG; Theis K; Blana A; Fortmüller L; Laakmann S; Hermann S; Aleynichenko E; Steinfurt J; Volkery D; Riemann B; Kirchhefer U; Franz MR; Breithardt G; Carmeliet E; Schäfers M; Maier SK; Carmeliet P; Kirchhof P
    Cardiovasc Res; 2010 Jul; 87(1):60-72. PubMed ID: 20110334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of channel blockers on cardiac alternans.
    Xia H; Zhao X; Bains J; Wortham DC
    Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():2823-6. PubMed ID: 19964269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.